Treace Medical Concepts TMCI reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Treace Medical Concepts missed estimated earnings by 15.0%, reporting an EPS of $-0.23 versus an estimate of $-0.2.
Revenue was up $9.31 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 9.38% drop in the share price the next day.
Here's a look at Treace Medical Concepts's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.20 | -0.12 | -0.12 | |
EPS Actual | -0.16 | -0.12 | -0.12 | -0.10 |
Revenue Estimate | 26.03M | 32.27M | 21.00M | 18.93M |
Revenue Actual | 29.05M | 33.44M | 21.62M | 20.65M |
To track all earnings releases for Treace Medical Concepts visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.